Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIVE MD in symptomatic dry eye
NCT00987727Phase 4Completed
- Sponsor
- Allergan
- Start
- Nov 2009
- Primary completion
- Jul 2010
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carboxymethylcellulose sodium + glycerin in dry eye syndrome (DED), sponsored by Allergan. Started Nov 2009; status: completed.
02
Drugs
carboxymethylcellulose sodium + glycerin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00987727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00987727.